Hussman Investment Trust has filed a summary prospectus for its Hussman Strategic Total Return Fund, which will take effect on November 1, 2026. This document provides crucial information about the fund's investment strategies, fees, and operational structures, which are designed to attract and inform potential investors.
The filing, dated October 30, 2026, is significant as it outlines the fund's objectives, which include seeking long-term total return from income and capital appreciation. The prospectus also details the fees associated with investing in the fund, which may influence investor decisions in a competitive market.
Hussman Investment Trust, incorporated in Ohio, operates within the investment sector and is known for its focus on strategic management of fixed-income securities. The firm has been active in filing various forms with the SEC, including a recent series of 497K forms, which provide updates on its funds and investment strategies.
Background
Hussman Investment Trust, with a Central Index Key (CIK) of 0001110502, is an investment firm that focuses on mutual funds. The company is incorporated in Ohio and has been filing various forms with the SEC, including the most recent 497K on October 30, 2026. The firm’s primary offering is the Hussman Strategic Total Return Fund, which is identified by the ticker symbol HSTRX.
What the Filing Says
The recent filing includes a summary prospectus for the Hussman Strategic Total Return Fund, stating, "Before you invest, you may want to review the Fund's Prospectus and Statement of Additional Information (SAI), which contain more information about the Fund and its risks." This highlights the importance of reviewing detailed information before making investment decisions.
Impact
This update may affect current and potential investors in the Hussman Strategic Total Return Fund by providing clarity on the fund's investment strategies and fee structure. It also serves as a reminder of the competitive nature of the mutual fund industry, where transparency and detailed information can significantly influence investor choices.
What's Next
The filing does not say what happens next, but it indicates that the fund's management is committed to maintaining transparency and providing detailed information to investors.
Read Next
CEO Mark Jeffery Reports Significant Stock Transactions
Moritz Robert Edward Jr. acquires shares of Northern Trust
Medpace Holdings' General Counsel Sells 1,245 Shares
Cytokinetics CEO Robert I. Blum Executes Stock Transactions
Etsy's Josh Silverman Sells 41,500 Shares in Recent Filing
Director Henry B. Smith sells 4,893 shares of Axis Capital






